Goat Anti-Human IgG Fc (HRP) preadsorbed
5
(2 Reviews)
|
(40 Publications)
Goat Anti-Human IgG Fc (HRP) is a preadsorbed secondary antibody for chemiluminescent detection. Ideal for Western blot. Suitable for Western blot, IHC, ELISA and ICC.
- Preadsorbed to prevent cross-reactivity and reduce background staining
- Cited in over 30 publications
View Alternative Names
Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2
- WB
Supplier Data
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
This data was developed using ab289981, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concnetration are 5% NFDM/TBST.
ab289981 detects a ranged of myc tagged proteins in WB.
All lanes:
Western blot - Anti-Myc tag antibody [Hyper-myc] (<a href='/en-us/products/primary-antibodies/myc-tag-antibody-hyper-myc-ab289981'>ab289981</a>) at 1/5000 dilution
Lane 1:
HEK-293T (human embryonic kidney) transfected with an empty vector (vector control), containing a myc-His-tag®, whole cell lysate at 1 µg
Lane 2:
HEK-293T transfected with cas9 ( S. Aureas) expression vector containing a myc-His-tag®, whole cell lysate at 1 µg
Lane 3:
HEK-293T transfected with human SNCA140 expression vector containing a myc-His-tag®, whole cell lysate at 1 µg
Lane 4:
HEK-293T transfected with human IDS expression vector containing a myc-His-tag®, whole cell lysate at 1 µg
Lane 5:
HEK-293T transfected with human NF2 S518A expression vector containing a myc-His-tag®, whole cell lysate at 1 µg
Lane 6:
HEK-293T transfected with human Alpha-synuclein expression vector containing a myc-His-tag®, whole cell lysate at 1 µg
Secondary
All lanes:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
Predicted band size: 49 kDa
false
Exposure time: 1s
- WB
Lab
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
All lanes:
Western blot - Anti-HMGB1 antibody [EPR21207] (<a href='/en-us/products/primary-antibodies/hmgb1-antibody-epr21207-ab213256'>ab213256</a>) at 1/100 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
SK-BR-3 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
parental HAP1(HOWT01) (human chronic myelogenous leukemia near-haploid cell ) whole cell lysate at 20 µg
Lane 6:
HMGB1 knockout HAP1 whole cell lysate at 20 µg
Lane 7:
MEF (mouse embryo fibroblast) whole cell lysate at 20 µg
Lane 8:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 9:
Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
false
- WB
Supplier Data
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 27043630).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-Rho A + B + C antibody [EPR18299] staining at 1/1000 dilution.
All lanes:
Western blot - Anti-RhoA + RhoB (ADP-ribosylated) antibody [VIF140-A1] (<a href='/en-us/products/primary-antibodies/rhoa-rhob-adp-ribosylated-antibody-vif140-a1-ab324028'>ab324028</a>) at 1/1000 dilution
Lane 1:
Untreated HT-22 (mouse hippocampal neuronal cell) whole cell lysate at 20 µg
Lane 2:
HT-22 treated with 500nM C3 for 6 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
Observed band size: 22 kDa,36 kDa
false
Exposure time: 26s
- WB
Supplier Data
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM/TBST Exposure Time : Lane 1 : 3 seconds, Lane 2-3 : 20 seconds. Negative control : Skeletal muscle. The identity of the bands between 27 kDa and 150 kDa are unknown. ab181602 was used as a loading control.
All lanes:
Western blot - Anti-TAGLN/Transgelin antibody [EPR21206] (<a href='/en-us/products/primary-antibodies/tagln-transgelin-antibody-epr21206-ab213273'>ab213273</a>) at 1/500 dilution
Lane 1:
Rat bladder tissue lysate at 20 µg
Lane 2:
Rat colon tissue lysate at 20 µg
Lane 3:
Rat skeletal muscle tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
Lab
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
Blocking and diluting buffer was 5% NFDM/TBST
All lanes:
Western blot - Anti-PLBD2 antibody [IGX4128H] (<a href='/en-us/products/primary-antibodies/plbd2-antibody-igx4128h-ab213295'>ab213295</a>) at 1/1000 dilution
Lane 1:
Mouse brain tissue lysate at 20 µg
Lane 2:
Mouse heart tissue lysate at 20 µg
Lane 3:
Human cerebellum tissue lysate at 20 µg
Lane 4:
Rat brain tissue lysate at 20 µg
Lane 5:
Rat heart tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
false
Exposure time: 4s
- I-ELISA
Lab
Indirect ELISA - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
Indirect ELISA showing primary antibody ab323000 binding to Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, ab272105). Plates were coated with Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, ab272105), Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera, ab272106) and Recombinant human coronavirus SARS spike glycoprotein (Tagged, ab270844) at 1000 ng/ml. Binding of ab323000 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution). Secondary antibody, Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) was used at 1 : 5000.
- I-ELISA
Lab
Indirect ELISA - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
Indirect ELISA showing primary antibody ab322272 binding to Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, ab272105). Plates were coated with Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Fc Chimera, ab272105) and Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera, ab272106) at 1000 ng/ml. Binding of ab322272 was assessed in a serial dilution range 0.016- 1000 ng/mL (a 3-fold serial dilution). Secondary antibody, Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) was used at 1 : 5000.
- WB
Lab
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
False colour image of Western blot : Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [8B12-C2] - Human IgG1 (Chimeric) (ab322272) staining at 1/500 dilution, shown in black; Mouse Monoclonal 6X His tag® (ab18184) loading control staining at 1/200 dilution, shown in red. In Western blot, ab322272 was shown to bind specifically to SARS-CoV and SARS-CoV-2 Spike Glycoproteins. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1 : 10000 and Goat anti-Mouse IgG H&L 680RD at 1 : 20000.
All lanes:
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 [8B12-C2] – Human IgG1 (Chimeric) (<a href='/en-us/products/primary-antibodies/sars-cov-2-spike-glycoprotein-s1-8b12-c2-human-igg1-chimeric-ab322272'>ab322272</a>) at 1/500 dilution
Lane 1:
Western blot - Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Active) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-spike-glycoprotein-s1-active-ab273068'>ab273068</a>) at 0.2 µg
Lane 2:
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD-His Recombinant Protein at 0.2 µg
Lane 3:
SARS-CoV Spike S1+S2 ECD-His Recombinant Protein at 0.2 µg
Secondary
Lanes 1 - 3:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
Lanes 1 - 3:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 120-160 kDa
false
Exposure time: 5s
- WB
Lab
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
Lane 1 : Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Active, His tagged) (ab273068) at 0.2 ug
Lane 2 : Recombinant SARS-COV-2 NSP2 protein (His tagged) at 0.2 ug
Performed under reducing conditions.
Observed band size : 135 kDa.
False colour image of Western blot : Rabbit monoclonal [EPR24852-116] to SARS-CoV-2 Spike Glycoprotein S1 - Human IgG1 (Chimeric), ab323000 staining at 1/500 dilution, shown in black; Mouse Monoclonal 6X His tag® (ab18184) loading control staining at 1/1000 dilution, shown in red. In Western blot, ab323000 was shown to bind specifically to SARS-CoV-2 spike glycoprotein S1. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1 : 10000 and Goat anti-Mouse IgG H&L 680RD at 1 : 20000.
Blocking buffer : 3% milk in TBS-0.1% Tween® 20 (TBS-T).
Exposure time : 30 Sec.
All lanes:
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [EPR24852-116] - Human IgG1 (Chimeric) (<a href='/en-us/products/primary-antibodies/sars-cov-2-spike-glycoprotein-s1-antibody-epr24852-116-human-igg1-chimeric-ab323000'>ab323000</a>) at 1/500 dilution
Lane 1:
Western blot - Recombinant human coronavirus SARS-CoV-2 Spike Glycoprotein S1 (Active) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-spike-glycoprotein-s1-active-ab273068'>ab273068</a>) at 0.2 µg
Lane 2:
Recombinant SARS-COV-2 NSP2 protein (His tagged) at 0.2 µg
Secondary
Lanes 1 - 2:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
Lanes 1 - 2:
Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 135 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature (PMID : 27043630).
In Western blot, Anti-Histone H3 antibody [EPR16987] - Nuclear Marker and ChIP Grade (ab176842) staining at 1/200000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
In Western blot, Anti-Rho A + B + C antibody [EPR18299] staining at 1/1000 dilution.
All lanes:
Western blot - Anti-RhoA + RhoB (ADP-ribosylated) antibody [VIF140-A1] (<a href='/en-us/products/primary-antibodies/rhoa-rhob-adp-ribosylated-antibody-vif140-a1-ab324028'>ab324028</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) transfected with an empty vector containing a myc-his-tag whole cell lysate at 20 µg
Lane 2:
293T transfected with an empty vector containing a myc-his-tag were treated with 500nM C3 for 30 minutes whole cell lysate at 20 µg
Lane 3:
293T transfected with an human RhoA expression vector containing a myc-his-tag whole cell lysate at 20 µg
Lane 4:
293T transfected with an human RhoA expression vector containing a myc-his-tag were treated with 500nM C3 for 30 minutes whole cell lysate at 20 µg
Lane 5:
293T transfected with an human RhoB expression vector containing a myc-his-tag whole cell lysate at 20 µg
Lane 6:
293T transfected with an human RhoB expression vector containing a myc-his-tag were treated with 500nM C3 for 30 minutes whole cell lysate at 20 µg
Lane 7:
293T transfected with an human RhoC expression vector containing a myc-his-tag whole cell lysate at 20 µg
Lane 8:
293T transfected with an human RhoC expression vector containing a myc-his-tag were treated with 500nM C3 for 30 minutes whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
Observed band size: 22 kDa,17 kDa
false
Exposure time: 1s
- WB
Supplier Data
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
False colour image of Western blot : Anti-SARS-CoV-2 Spike Glycoprotein S2 antibody [EPR25038-122] - BSA and Azide free - Human IgG1 (Chimeric) (ab324889) staining at 1/1000 dilution, shown in black.
In Western blot, ab324889 was shown to bind specifically to SARS-CoV-2 Spike Glycoprotein S2. Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1h at room temperature, washed again four times then imaged.
Blocking buffer : 3% milk in TBS-0.1% Tween® 20 (TBS-T)
All lanes:
Western blot - Anti-SARS-CoV-2 S Glycoprotein S2 antibody [EPR25038-122] - Human IgG1 (Chimeric) - BSA & Azide free (<a href='/en-us/products/primary-antibodies/sars-cov-2-spike-glycoprotein-s2-antibody-epr25038-122-human-igg1-chimeric-bsa-and-azide-free-ab324889'>ab324889</a>) at 1/1000 dilution
Lane 1:
Western blot - Recombinant Human coronavirus SARS-CoV-2 Spike Glycoprotein S2 (Fc Chimera) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-spike-glycoprotein-s2-fc-chimera-ab272106'>ab272106</a>) at 0.2 µg
Lane 2:
Western blot - Recombinant Human coronavirus SARS-CoV-2 nucleocapsid protein (His tag) (<a href='/en-us/products/proteins-peptides/recombinant-human-coronavirus-sars-cov-2-nucleocapsid-protein-his-tag-ab273530'>ab273530</a>) at 0.2 µg
Secondary
All lanes:
Western blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
Observed band size: 135 kDa
false
Exposure time: 10s
- Dot
Supplier Data
Dot Blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (AB98624)
Dot blot analysis of bat SARS-like coronavirus RsSHC014 Spike glycoprotein using ab317329 at 1 : 1000 followed by a Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1 : 10,000 dilution.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Dot Blot - Anti-bat SARS-like coronavirus RsSHC014 Spike glycoprotein antibody [abd166] (<a href='/en-us/products/primary-antibodies/bat-sars-like-coronavirus-rsshc014-spike-glycoprotein-antibody-abd166-ab317329'>ab317329</a>) at 1/1000 dilution
Lane 1:
293T cells transfected with an empty vector containing a myc-his tag whole cell lysate
Lane 2:
293T cells transfected with a Bat Spike glycoprotein expression vector containing a myc-his-tag whole cell lysate
Lane 3:
His-tagged bat SARS-like coronavirus RsSHC01 recombinant fragment protein
Secondary
All lanes:
Dot Blot - Goat Anti-Human IgG Fc (HRP) preadsorbed (ab98624) at 1/10000 dilution
false
Exposure time: 180s
Reactivity data
Product details
This antibody reacts with the Fc region of Human IgG
When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Target data
Additional targets
Publications (40)
Recent publications for all applications. Explore the full list and refine your search
Arthritis research & therapy 27:133 PubMed40604930
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 15:1490044 PubMed39640268
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 21:317 PubMed39627772
2024
Applications
Unspecified application
Species
Unspecified reactive species
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 39:153-165 PubMed39614966
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of bacteriology 206:e0031224 PubMed39530727
2024
Applications
Unspecified application
Species
Unspecified reactive species
Antiviral research 227:105914 PubMed38759930
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 7:294 PubMed38461214
2024
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed38127423
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:5948 PubMed37741831
2023
Applications
Unspecified application
Species
Unspecified reactive species
mAbs 15:2232087 PubMed37408314
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com